Yu Jung Kim
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 10%
- Cancer Research top 2%
- Public Health, Environmental and Occupational Health top 2%
- Co-authors
- Jee Hyun KimJong Seok LeeSe Hyun KimSo Yeon ParkKeun‐Wook LeeEunyoung KangIn Ah KimJin Won Kim
- Topics
- Palliative Care and End-of-Life Issues (41 papers)Lung Cancer Treatments and Mutations (35 papers)Cancer survivorship and care (27 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryJournal of Clinical Oncology
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
Yu Jung Kim
233 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 141
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 1.6k
- Molecular Biology 1.0k
- Cancer Research 729
- Public Health, Environmental and Occupational Health 657
Countries citing papers authored by Yu Jung Kim
This map shows the geographic impact of Yu Jung Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Jung Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Jung Kim more than expected).
Fields of papers citing papers by Yu Jung Kim
This network shows the impact of papers produced by Yu Jung Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Jung Kim. The network helps show where Yu Jung Kim may publish in the future.
Co-authorship network of co-authors of Yu Jung Kim
This figure shows the co-authorship network connecting the top 25 collaborators of Yu Jung Kim. A scholar is included among the top collaborators of Yu Jung Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Jung Kim. Yu Jung Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 23 | |
| 4 | 1 | |
| 5 | 15 | |
| 6 | 5 | |
| 7 | 3 | |
| 8 | 10 | |
| 9 | 7 | |
| 10 | 13 | |
| 11 | 12 | |
| 12 | 2 | |
| 13 | 2 | |
| 14 | 19 | |
| 15 | 14 | |
| 16 | 7 | |
| 17 | 18 | |
| 18 | 8 | |
| 19 | 53 | |
| 20 | 131 |
About Yu Jung Kim
Yu Jung Kim is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine, having authored 247 papers that have together received 5.1k indexed citations. Recurring topics across this work include Palliative Care and End-of-Life Issues (41 papers), Lung Cancer Treatments and Mutations (35 papers) and Cancer survivorship and care (27 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (1.6k citations) and Cancer Research (729 citations). Yu Jung Kim has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Jee Hyun Kim, Jong Seok Lee, Se Hyun Kim, So Yeon Park, Keun‐Wook Lee, Eunyoung Kang, In Ah Kim, Jin Won Kim, Dae Seog Heo and Tae Min Kim. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.